People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
IST is an Australian company, specialising in the development of monoclonal antibody therapies for multiple myeloma and other blood cancers.
Professor Raison and Dr Rosanne Dunn spearheaded the establishment of PacMab in 2001 to commercialise monoclonal antibody technology developed at UTS over 10 years, and for which ...
IF biologist Rosanne Dunn and her team find a cure for bone marrow cancer, their success will be a textbook case of how to commercialise research.
Most of the PacMab research team are UTS doctoral and masters graduates including Co-founder and Director of Research Dr Rosanne Dunn, Dr Parisa Asvadi and Darren Jones.
The team headed by Professor Raison comprises doctoral students Mr Andre Choo from Singapore, Ms Susan Lemke and postdoctoral researcher Dr Rosanne Dunn, whose doctoral thesis ...
IST is an Australian company, specialising in the development of monoclonal antibody therapies for multiple myeloma and other blood cancers.
Rosanne Dunn, BSc (Hons) (Cape Town), MSc (Natal), PhD (UTS) Tel : +61 2 9514 4060 Email : Rosanne.Dunn@pacmab.com Lewis F Gibson, BSc (Hons) (Edin), PhD (Melb), FASM
The team headed by Professor Raison comprises doctoral students Mr Andre Choo from Singapore, Ms Susan Lemke and postdoctoral researcher Dr Rosanne Dunn, whose doctoral ...
Linkedin
University of Technology Sydney (Educational Institution; Higher Education industry): Research Associate, (1997-2001)
Bioprocessing Technology Centre ...